PHILADELPHIA, Sept. 22, 2016 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced the resignation of its chief of scientific affairs, Mahendra Dedhiya, Ph.D., effective October 21, 2016.

http://photos.prnewswire.com/prnvar/20150417/199461LOGO

"Mahendra joined Lannett last year as part of our acquisition of Silarx Pharmaceuticals," said Arthur Bedrosian, chief executive officer of Lannett. "He intends to become a faculty member and researcher at Long Island University, where he had been teaching part time. We thank him for his service to Lannett and wish him well."

The company said a search is underway for a new head of research and development.

About Lannett Company, Inc.:
Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications. For more information, visit the company's website at www.lannett.com. 



    Contact:                        Robert Jaffe

                                     Robert Jaffe Co.,
                                     LLC

                                    (424) 288-4098

Logo - http://photos.prnewswire.com/prnh/20150417/199461LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lannett-announces-resignation-of-mahendra-dedhiya-phd-chief-of-scientific-affairs-300332195.html

SOURCE Lannett Company, Inc.